Member Info for imac1

3.3 -3.5p already so glad i invested of the back of a lot of research this morning already in profit ;-)

Hi Charlie

Thanks for your reply and i have taken the dip but it has pushed the price up quite a bit haha

The potential here is mind boggling to be honest and i can see many many multiples of the current SP

Next stop over 10p for starters.

Hey looking to diversify from Covid plays with some nice profits. Reading the latest posts and company webisite/rns/podcasts surely this is way undervalued or too good to be true..!!!

If undervalued then it must be one of the most undervalued stocks on AIM on potential alone.??!!!

This placing comes at the wrong time for the company should they have held off a few more days they could have done it at 160p +

For those that are in big profit i strongly recommend SNG for further gains over the next few weeks.

Good luck whatever you do all.

Lots of money made for wise day traders but the pump and dump crew have ruined it and driven the SP up way too fast.
Almost touched 300p before RNS of 80p placing ouch...

That is why investing in a company with an already well funded bank balance is key to long term gains.

SNG is my number one holding at the moment if trials are successful we will be bought out by a big PHARMA no doubt about that.

I’m guessing you don’t have live pricing scary dude it’s already £2.94 to sell...!!!!

An sell at 2.90 now ......wow

2.88 paid this is insane

https://masterinvestor.co.uk/equities/small-cap-bounce-back-pharma-stocks-fighting-covid-19/

Can’t wait for tonights Panorama should highlight SNG for all the right reasons. We are hear to make money but also remember the greater good this product could do for potentially one of your friends, family and the world as a whole.

Never invested in a company where the results are as important to the world as to my share portfolio.

Feels good

Moving up again 71-73p
Finally caught up on all the fantastic news great work everyone. As I keep saying SNG will be firmly in the sights of the BIG Pharmaceutical companies and will be bought out of the back of positive Phase 2 results.
Hold for Gold

As I alluded to in my 13:58 post big money can be paid for pre clinical / discovery stage assets and SNG is already ahead on the curve in that sense with SG016.

Examples:
In the gene therapy field, Neurocrine Biosciences signed a deal potentially worth $1.8 billion—including a $165 million upfront payment—with Voyager Therapeutics to acquire development and com- mercialization rights to four gene therapy programs. The deal includes VY-AADC, a phase 2 asset for Parkinson disease, and VY-FXN01, which is in preclinical development for Friedreich ataxia. Both gene therapies are based on the AAV platform.

Finally, another notable trend was that the majority of the top deals concentrated on preclinical or discovery-stage assets (60%), indicating the continuing importance of early access to innovation. Among those in Figure 2, a notable example is Genentech’s deal with SkyHawk signed in July. Potentially worth more than $2 billion, it involves the application of SkyHawk’s platform to identify compounds that target RNA, an emerging area of small-molecule drug discovery that has provided the basis for several companies to be formed in recent years.

Great link hard to put value on SNG I’m sure we will all try the closet one I could find on the list in relative value terms was this

“a notable example is Genentech’s deal with SkyHawk signed in July. Potentially worth more than $2 billion, it involves the application of SkyHawk’s platform to identify compounds that target RNA, an emerging area of small-molecule drug discovery that has provided the basis for several companies to be formed in recent years.

Like I say it’s hard to compare any of the companies as they all have unique features but shows how much Big Pharma's will pay for even pre clinical and discovery stage assets..!!!

If SNG come good on this then I say a minimum of £1B but who knows a bidding war could start and we end up at a much higher price. For those of us luck enough to be invested right now it’s the perfect storm to become very very wealthy nothing moves in value like a Pharma share as has been seen with NCYT and others over the last few months.

GLTA

This is huge news bought in at 70p a few weeks back and topped up at 61.5 on news. This will head towards £2 on anticipation of results in June and if the trial has gone successfully then we will see 100% that day. For me right now this is one of the top 3 Covid plays.
Well done to all old and new investors

For clarity just friendly heads up.

I’m invested here for the long run also at 25p

Some may be following heads up RNS over at SNG sounds promising for all those invested ;-)

Must be something going on ! Anyone car to shed light on the matter?

Noticed this has just turned blue well that was unexpected seems like there may be substance in yesterday’s rise. Not invested but on my watchlist congrats to those who held there nerve looks like going on a run up.

Wow off we go again ..!!!

Lets crack 9 first then we could be back up to 10 in no time